Menu

Charles Bair represents private and public companies in corporate and securities matters, including private financings, public offerings, M&A, tender offers, joint ventures, corporate governance matters, Securities and Exchange Commission reporting and compliance and employment and compensation arrangements.

Download full bio 

Experience

  • Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion 

  • Kronos Bio – $288 million IPO 

  • Turning Point Therapeutics - $192 Million IPO 

  • Allogene Therapeutics – $372.6 Million IPO 

  • Cidara Completes Initial Public Offering  

  • View all

Education

  • Stanford Law School
    JD, 2002

  • University of California, Berkeley
    MS, Mechanical Engineering
    1996

  • University of California, San Diego
    BS, Mechanical Engineering
    magna cum laude, Tau Beta Pi, 1995


Admissions & Credentials

California

Memberships

  • American Bar Association

  • San Diego County Bar Association

  • State Bar of California